fda approval for tirzepatide says the weight-loss drug shortage is over Lilly's new drug Mounjaro (tirzepatide

Deal of the Week Regeneron will pay Tessera Pharmaceuticals $150 million upfront as part of a gene-editing partnership for a rare liver and lung disease, known as alpha-1 antitrypsin deficiency

The most affected areas of the review include section 3.2, Vitamin D levels are often low in persons with PD, where the review discussed the observation that vitamin D levels appear to be lower in persons with PD than in control populations

Why Researchers Choose Canvax Bac Water Canvax is a European manufacturer specialized in enzymes, buffers, molecular biology reagents, and laboratory essentials

Methods for the Detection of ROS in Human Sperm Samples

Ozempic for weight loss is off-label and often denied by insurers